¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"clinical syndrome"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • Werner¡¯s syndrome
    º£¸£³ÊÁõÈıº
  • Wernicke¡¯s syndrome
    º£¸£´ÏÄÉÁõÈıº
  • X-linked lymphoproliferative syndrome
    X¿¬°ü¸²ÇÁ±¸Áõ½ÄÁõÈıº
  • Zollinger-Ellison syndrome
    Á¹¸µ°Å-¿¤¸®½¼ÁõÈıº
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • anterior chamber cleavage syndrome
    Àü¹æ(°¢)ºÐ¸®ºÎÀüÁõÈıº
  • anterior choroidal artery occlusion syndrome
    Àü¸Æ¶ôÃѵ¿¸Æ Æó¼âÁõÈıº.
  • anterior cornual syndrome
    Àü°¢ÁõÈıº(îñÊÇñøý¦ÏØ).
  • anterior scalene syndrome
    Àü»ç°¢±ÙÁõÈıº(îñÞØÊÇÐÉñøý¦ÏØ).
  • anterior spinal artery syndrome
    Àüô¼öµ¿¸ÆÁõÈıº(¡­ñøý¦ÏØ).
  • anterior spinal syndrome
    Àü»èÁõÈıº(¡­ñøý¦ÏØ).
  • anterior tibial syndrome
    Àü°æ°ñÁõÈıº
  • anterolateral syndrome
    ô¼öÀüÃø°¢ÁõÈıº(ô±âÐîñö°ÊÇñøý¦ÏØ).
  • antibody deficiency syndrome
    Ç×ü°áÇÌÁõÈıº(ù÷ô÷ÌÀù¹ñøý¦ÏØ).
  • anticardiolipin syndrome
    Ç×Ä«µð¿À¸®ÇÉÁõÈıº
  • anticardiolipin syndrome
    Ç×Ä«¸£µð¿Ã¸®ÇÉÁõÈıº
  • antiphospholipid syndrome
    Ç×ÀÎÁöÁúÁõÈıº
  • anxiety syndrome
    ºÒ¾ÈÁõÈıº(¡­ñøý¦ÏØ).
  • aortic arch syndrome
    ´ëµ¿¸Æ±ÃÁõÈıº(¡­ñøý¦ÏØ).
  • aortic arch syndrome
    ´ëµ¿¸Æ±Ã ÁõÈıº(¡­Ïáñøý¦ÏØ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • dysconnection syndrome
    ºÐ¸®ÁõÈıº.
  • dysglandular syndrome
    ³»ºÐºñ¼±½ÇÁ¶ÁõÈıº(Ò®ÝÂù²àÍã÷ðàñøý¦ÏØ).
  • dyskinetic syndrome
    ¿îµ¿Àå¾ÖÁõÈıº.
  • dysplastic nevus syndrome
    ÀÌÇü¼º ¸ð¹Ý ÁõÈıº
  • dysuria-pyuria syndrome
    ¹è´¢Àå¾Ö-³ó´¢ ÁõÈıº
  • early postprandial postgastrectomy syndrome
    Á¶±â½ÄÈļº À§ÀýÁ¦ÈÄÁõÈıº.
  • easy bruising syndrome => purpura simplex
  • eaton-lambert syndrome
    ÀÌÆ°¶÷¹öÆ®ÁõÈıº
  • ectopic ACTH syndrome
    À̼Ҽº ºÎ½ÅÇÇÁúÀÚ±ØÈ£¸£¸óÁõÈıº
  • ectrodactyly ectodermal dysplasia cleftlip syndrome =EEC s.
    ÁöÁö°á¼Õ ¼º ¿Ü¹è¿± ÀÌÇü¼º Åä¼øÁõÈıº(ò¦ò¿ÌÀáßàõèâÛÏç¨ì¶û¡à÷÷Íâîñøý¦ÏØ).
  • edinger-westphal syndrome
    ¿¡µù°Å-¿þ½ºÆ®ÆÈ ÁõÈıº
  • edwards syndrome
    ¿¡µå¿öµå ÁõÈıº(¡­ñøý¦ÏØ)
  • effort syndrome
    ¿¡Æ÷Æ®ÁõÈıº
  • effort syndrome
    ÇÇ·ÎÁõÈıº
  • eggwhite syndrome
    ÈòÀÚÀ§ÁõÈıº, ³­¹éÁõÈıº.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
ACLPS Academy of Clinical Laboratory Physicians and Scientists
ACP accessory conduction pathway; acid phosphatase; acyl carrier protein; American College of Pathologis...
ACTG AIDS Clinical Trial Group
AFCR American Federation for Clinical Research
AIDSDRUGS clinical trials of acquired immunodeficiency drugs [MEDLARS data base]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
BMS Burning Mouth Syndrome
CFS Cancer Family Syndrome
CDGS Carbohydrate Deficient Glycoprotein Syndrome
CSS Carotid Sinus Syndrome
C.T.S. Carpal Tunnel Syndrome
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • milk alkali syndrome
    ¿ìÀ¯ ¾ËÄ®¸® ÁõÈıº
    ¿À·£ ±â°£ µ¿¾È ¿ìÀ¯¿Í Èí¼ö¼º ¾ËÄ®¸® Á©À» ¼¶ÃëÇÔÀ¸·Î½á ÃÊ·¡µÇ´Â °íÄ®½· Ç÷Áõ¿¡ ÀÇÇÏ¿© ÀϾ´Â ÁõÈıºÀÌ´Ù. °íÄ®½· ´¢ÁõÀ̳ª ÀúÀλó Ç÷ÁõÀº ¼ö¹ÝµÇÁö ¾ÊÀ¸³ª, ÁߵÀÇ alaklosis, Á¤»ó Ç÷û
  • mineralocorticoid exess syndrome
    ¿°·ù ÄÚ¸£Æ¼ÄÚÀ̵å Áõ´ÙÁõ
  • mixed cryoglobulin syndrome
    È¥ÇÕ Çѳà ±Û·ÎºÒ¸° ÁõÈıº
  • monofixation syndrome
    ´Ü¾È Áֽà ÁõÈıº
  • motor syndrome
    ¿îµ¿ ÁßÃß ÁõÈıº
  • mucocutaneous ocular syndrome
    ÇǺΠÁ¡¸· ¾È ÁõÈıº
  • Muenchausen's syndrome
    ¹Â¿£ÇÏ¿ìÁ¨ ÁõÈıº
    ±Ø´ÜÀûÀÎ ÇãÀ§ÀÇ º´·ÂÀ» ¸»Çϸç, ¶§·Î´Â ±Þ¼º º¹ºÎ Áõ»ó, ƯÈ÷ ÃâÇ÷, ¿Ü»ó µîÀ» °¡ÀåÇϸ鼭 ÀÔ¿øÀ» ÇÏ´Ù°¡ ÀÚ¹ßÀûÀ¸·Î Åð¿øµµ ÇÏ´Â ±â±«ÇÑ »óÅ·Π´ë°³ È÷½ºÅ׸®, ºÐ¿­Áõ ¶Ç´Â ÇÇÇã¾Ö ȯÀÚ.
  • multiple hamartoma syndrome
    ´Ù¹ß¼º °ú¿ÀÁ¾ ÁõÈıº
    ´Ù¹ß¼ºÀÌ¸ç ¸ð¹Ý ¸ð¾çÀÎ ¿Ü¹è¿±¼º, Á߹迱¼º ¹× ³»¹è¿±¼ºÀÇ ½Å»ý¹°¼º ±âÇüÀ» Ư¡À¸·Î ÇÏ´Â À¯Àüº´. ¾ó±¼ ¹× ±¸°­ Á¡¸·ÀÇ ±¸ÁøÀÌ °¡Àå Æ¯Â¡ÀûÀÎ º´º¯ÀÌ´Ù. ±× ¿ÜÀÇ º´º¯Àº ÇǺÎ, °©»ó¼±
  • multiple lentigines syndrome
    ´Ù¹ß¼º ÈæÀÚ ÁõÈıº
    »ó¿°»öü¼º ¿ì¼ºÀÇ À¯Àü¼º ÁõÈıºÀ¸·Î¼­ ´Ù¹ß¼º °ËÀº »ç¸¶±Í, ¹«ÁõÈıº¼º ½ÉÀå °áÇÔ. ƯÀÌÇÑ ¾ó±¼ ¸ð¾ç, Æóµ¿¸Æ ÇùÂø, Áö°¢ ½Å°æ¼º ³­Ã», °ñ°Ý ÀÌ»ó, ¾ç¾È °Ý¸®, ¼º±â ±âÇü µîÀ» ³ªÅ¸³½´Ù.
  • multiple neuroma syndrome
    ´Ù¹ß¼º ½Å°æÁ¾ ÁõÈıº
  • Munchausen's syndrome
    ½Åü Áõ»óÀ» ¼ö¹ÝÇÑ °¡À强 Áúȯ
    ÀüºÎ °ÅÁþ¸»ÀÎ ±×·²µíÇÑ º´·ÂÀ» À̾߱âÇϸ鼭 ½À°üÀûÀ¸·Î ÀÔ¿ø Ä¡·á¸¦ ¹Þ´Â »óÅÂ.
  • muscle compartment syndrome
    ±Ù ±¸¿ª ÁõÈıº
    ±Ù ±¸¿ª ³»ÀÇ »ê¼Ò ºÎÁ·À¸·Î ÀÎÇÏ¿© ±ÙÀ°¿¡ ÅëÁõÀ̳ª »»»»ÇÔÀÌ ¹ß»ýÇÑ °Í.
  • myasthenia gravis syndrome
    ÁßÁõ ±Ù¹«·Â ÁõÈıº
  • myeloblastic syndrome
    °ñ¼ö¾Æ±¸ ÁõÈıº
  • myelodysplastic syndrome
    °ñ¼ö ÀÌÇü¼º ÁõÈıº
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
marfan syndrome <radiology> Connective-tissue disorder: autosomal dominant, 15% sporadic, cardiovascular system (probable cause of death in 93%), aortic aneurysm (mostly ascending), dilatation of aortic sinuses, aortic dissection, coarctation, musculoskeletal system, tall stature, long limbs, arachnodactyly, lax joints, scoliosis (60%) / kyphosis / pectus, eye, lens subluxation Cf: homocystinuria More info: Marfan syndrome
(12 Dec 1998)
Marie-Robinson syndrome <syndrome> Insomnia and mild melancholia associated with alimentary levulosuria.
(05 Mar 2000)
Marinesco-Garland syndrome <syndrome> A rare neurologic disorder characterised by cerebellolental degeneration with mental retardation; autosomal recessive inheritance.
Synonym: cataract-oligophrenia syndrome, Marinesco-Sjogren syndrome, Torsten Sjogren's syndrome.
(05 Mar 2000)
Marinesco-Sjogren syndrome <syndrome> A rare neurologic disorder characterised by cerebellolental degeneration with mental retardation; autosomal recessive inheritance.
Synonym: cataract-oligophrenia syndrome, Marinesco-Sjogren syndrome, Torsten Sjogren's syndrome.
(05 Mar 2000)
verner-morrison syndrome <radiology> WDHA syndrome, watery diarrhoea, hypokalaemia, achlorhydria, vasoactive intestinal peptide (VIP) secreted by, pancreatic isleT-cell tumour (VIPoma)
(12 Dec 1998)
Vernet's syndrome <syndrome> A syndrome characterised by paralysis of the motor components of the glossopharyngeal, vagus, and accessory cranial nerves as they lie in the posterior fossa; it is most commonly the result of head injury.
(05 Mar 2000)
Maroteaux-Lamy syndrome <biochemistry, syndrome> An error of mucopolysaccharide metabolism due to deficiency of the lysosomal enzyme arylsulphatase B.
It is characterised by excretion of dermatan sulfate in the urine, growth retardation, lumbar kyphosis, sternal protrusion, genu valgum, usually hepatosplenomegaly, and no mental retardation.
Onset occurs after two years of age.
Inheritance: autosomal recessive.
Synonym: polydystrophic dwarfism, mucopolysaccharidosis type VI.
(05 Mar 2000)
Marshall syndrome <syndrome> Syndrome of mid-face hypoplasia, cataract, sensorineural hearing loss, and hypohidrosis. It is disputed whether this syndrome is distinct from Stickler's syndrome.
(05 Mar 2000)
carotid artery occlusive syndrome <syndrome> Aortic arch syndrome, also referred to by many as vertebral-basilar artery disease, carotid artery occlusive syndrome and subclavian steal syndrome.
Characterised by a constellation of signs and symptoms which occur secondary to abnormalities in the major arteries which extend off of the aortic arch. These abnormalities are structural and most often secondary to the effects of atherosclerosis, blood clots, trauma or a congenital abnormality.
Symptoms of this condition include various neurologic symptoms, reduction in pulse and changes in blood pressure.
(27 Sep 1997)
carotid sinus syndrome <syndrome> Stimulation of a hyperactive carotid sinus, causing a marked fall in blood pressure due to vasodilation, cardiac slowing, or both; syncope with or without convulsions or A-V block may occur.
Synonym: Charcot-Weiss-Baker syndrome.
(05 Mar 2000)
Martorell's syndrome <syndrome> Aortic arch syndrome, also referred to by many as vertebral-basilar artery disease, carotid artery occlusive syndrome and subclavian steal syndrome is characterised by a constellation of signs and symptoms which occur secondary to abnormalities in the major arteries which extend off of the aortic arch. These abnormalities are structural and most often secondary to the effects of atherosclerosis, blood clots, trauma or a congenital abnormality. Symptoms of this condition include various neurologic symptoms, reduction in pulse and changes in blood pressure.
(27 Sep 1997)
masa syndrome <syndrome> MASA stands for mental retardation, aphasia, shuffling gait, and adducted thumbs.
Features of the syndrome include (1) neurologically: mental retardation and aphasia (lack of speech); (2) limbs: adducted (clasped) thumbs, absent extensor pollicis longus and/or brevis muscles to the thumb, shuffling gait, and leg spasticity; (3) growth: small body size; (4) skeleton: lumbar lordosis (sway back).
It is inherited as an x-linked trait and so affects mainly boys. Alternative names for masa include clasped thumb and mental retardation, congenital clasped thumb with mental retardation, adducted thumb with mental retardation, and the gareis-mason syndrome.
inheritance: X-linked
(29 Dec 1998)
carpal tunnel syndrome <syndrome> A condition where there is a disturbance of median nerve function in the wrist as the nerve passes through the carpal tunnel.
A buildup of scar tissue (inside the carpal tunnel) can lead to this surgically correctable problem. Often treated with splinting and anti-inflammatory agents.
(27 Sep 1997)
Carpenter's syndrome <syndrome> The association of primary hypothyroidism, primary adrenocortical insufficiency, and diabetes mellitus.
Origin: C. C. J. Carpenter
Synonym: acrocephalopolysyndactyly.
Origin: G. Carpenter
(05 Mar 2000)
vertical retraction syndrome <syndrome> A retraction of the globe and pseudoptosis on attempted adduction; due to co-innervation of the horizontal recti. Sometimes there is an inability to abduct the affected eye (type 1), or adduct the affected eye (type 2), or both (type 3).
Synonym: Duane's syndrome.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
ÅëÇÕ°Ë»ö ¿Ï·á